INMED PHARMACEUTICALS INC (INM)
CA4576376012 - Common Stock
| MRQ (2023-12-31) | 2023 (2023-6-30) | 2022 (2022-6-30) | 2021 (2021-6-30) | 2020 (2020-6-30) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 9.53M | 8.91M | 6.18M | 7.36M | 5.81M | |||
| Marketable Securities | 44.46K | 40.00K | 40.00K | 50.00K | 40.00K | |||
| Receivables | 372.87K | 260.00K | 90.00K | 10.00K | 50.00K | |||
| Inventories | 744.84K | 1.62M | 2.49M | N/A | N/A | |||
| Other Current Assets | 1.11M | 500.00K | 800.00K | 960.00K | 420.00K | |||
| Total Current Assets | 11.81M | 11.33M | 9.60M | 8.38M | 6.31M | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.48M | 720.00K | 900.00K | 330.00K | 400.00K | |||
| Intangibles | 1.86M | 1.95M | 2.11M | 1.06M | 1.09M | |||
| Other Non-Current Assets | 100.00K | 100.00K | 180.00K | 10.00K | 0.00 | |||
| Total Non-Current Assets | 3.45M | 2.78M | 3.19M | 1.40M | 1.49M | |||
| TOTAL ASSETS | 15.26M | 14.11M | 12.79M | 9.78M | 7.80M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | 80.00K | 70.00K | |||
| Accrued Expenses | 1.24M | 1.44M | 1.65M | 80.00K | 70.00K | |||
| Accounts Payable | 306.46K | 540.00K | 1.17M | 2.13M | 1.61M | |||
| Other Current Liabilities | 130.43K | 20.00K | 500.00K | N/A | N/A | |||
| Total Current Liabilities | 1.68M | 2.00M | 3.32M | 2.22M | 1.68M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 802.78K | 20.00K | 390.00K | 190.00K | 250.00K | |||
| Total Non-Current Liabilities | 802.78K | 20.00K | 390.00K | 180.00K | 240.00K | |||
| TOTAL LIABILITIES | 2.48M | 2.02M | 3.71M | 2.40M | 1.92M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -105.42M | -101.40M | -93.45M | -74.85M | -64.65M | |||
| Additional Paid In Capital | 38.12M | 35.74M | 31.68M | 21.51M | 17.76M | |||
| Common Shares | 79.94M | 77.62M | 70.72M | 60.59M | 53.07M | |||
| Other Shareholders' Equity | 128.57K | 130.00K | 130.00K | 130.00K | -300.00K | |||
| Shares Outstanding | 5.67M | 3.33M | 650.00K | 320.00K | 210.00K | |||
| Tangible Book Value per Share | 1.92 | 3.04 | 10.72 | 19.75 | 22.81 | |||
| Total Shareholders' Equity | 12.77M | 12.09M | 9.08M | 7.38M | 5.88M | |||
| TOTAL LIABILITIES AND EQUITY | 15.26M | 14.11M | 12.79M | 9.78M | 7.80M | |||
| Statistics | ||||||||
| Current Ratio | 7.03 | 5.67 | 2.89 | 3.77 | 3.76 | |||
| Return On Assets (ROA) | -41.68% | -56.34% | -145.43% | -104.29% | -114.62% | |||
| Return On Equity (ROE) | -49.78% | -65.76% | -204.85% | -138.21% | -152.04% | |||
All data in USD